tiprankstipranks
Trending News
More News >
StemCell Institute (JP:7096)
:7096
Japanese Market

StemCell Institute (7096) Ratios

Compare
0 Followers

StemCell Institute Ratios

JP:7096's free cash flow for Q1 2025 was ¥0.62. For the 2025 fiscal year, JP:7096's free cash flow was decreased by ¥ and operating cash flow was ¥0.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.22 1.20 1.20 1.32 1.37
Quick Ratio
1.21 1.19 1.19 1.31 1.36
Cash Ratio
0.71 0.74 0.76 0.97 1.15
Solvency Ratio
0.07 0.11 0.11 0.09 0.07
Operating Cash Flow Ratio
0.00 0.11 0.09 0.03 0.15
Short-Term Operating Cash Flow Coverage
0.00 6.96 158.74 0.00 0.00
Net Current Asset Value
¥ 430.09M¥ 299.38M¥ 664.58M¥ 1.03B¥ 1.07B
Leverage Ratios
Debt-to-Assets Ratio
0.06 0.07 <0.01 <0.01 0.00
Debt-to-Equity Ratio
0.18 0.20 <0.01 <0.01 0.00
Debt-to-Capital Ratio
0.15 0.16 <0.01 <0.01 0.00
Long-Term Debt-to-Capital Ratio
0.14 0.14 0.00 0.00 0.00
Financial Leverage Ratio
3.01 2.85 2.43 2.53 2.48
Debt Service Coverage Ratio
5.12 7.53 191.49 0.00 8.54K
Interest Coverage Ratio
77.83 348.18 0.00 0.00 8.41K
Debt to Market Cap
0.06 0.04 <0.01 0.00 0.00
Interest Debt Per Share
47.10 50.79 0.86 0.57 <0.01
Net Debt to EBITDA
-5.88 -3.86 -5.31 -8.64 -11.35
Profitability Margins
Gross Profit Margin
61.82%63.16%63.51%63.88%62.36%
EBIT Margin
11.16%21.16%16.68%14.23%11.93%
EBITDA Margin
16.22%25.95%21.52%18.36%17.37%
Operating Profit Margin
10.66%15.62%16.68%14.23%12.74%
Pretax Profit Margin
11.10%21.12%17.79%13.34%11.93%
Net Profit Margin
7.30%14.40%12.53%9.47%7.50%
Continuous Operations Profit Margin
7.30%14.40%12.53%9.47%7.50%
Net Income Per EBT
65.83%68.20%70.46%70.99%62.91%
EBT Per EBIT
104.08%135.17%106.66%93.75%93.66%
Return on Assets (ROA)
2.53%5.14%4.75%3.41%2.56%
Return on Equity (ROE)
7.52%14.68%11.55%8.62%6.36%
Return on Capital Employed (ROCE)
8.22%13.15%14.87%12.50%10.49%
Return on Invested Capital (ROIC)
5.32%8.78%10.46%8.87%6.60%
Return on Tangible Assets
2.60%5.24%4.78%3.42%2.58%
Earnings Yield
2.40%2.78%1.61%0.77%0.66%
Efficiency Ratios
Receivables Turnover
1.31 1.46 1.57 1.84 0.00
Payables Turnover
29.31 39.60 25.65 25.03 22.39
Inventory Turnover
17.93 19.36 21.42 19.20 16.70
Fixed Asset Turnover
2.34 2.32 3.73 3.23 2.75
Asset Turnover
0.35 0.36 0.38 0.36 0.34
Working Capital Turnover Ratio
3.33 3.33 2.66 1.87 2.11
Cash Conversion Cycle
286.47 259.82 235.82 202.87 5.55
Days of Sales Outstanding
278.57 250.18 233.02 198.44 0.00
Days of Inventory Outstanding
20.35 18.85 17.04 19.01 21.85
Days of Payables Outstanding
12.46 9.22 14.23 14.58 16.30
Operating Cycle
298.92 269.03 250.05 217.46 21.85
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 45.67 32.66 9.73 46.33
Free Cash Flow Per Share
0.00 -0.99 12.98 3.88 26.14
CapEx Per Share
0.00 46.65 19.68 5.85 20.19
Free Cash Flow to Operating Cash Flow
0.00 -0.02 0.40 0.40 0.56
Dividend Paid and CapEx Coverage Ratio
0.00 0.64 1.66 1.66 2.30
Capital Expenditure Coverage Ratio
0.00 0.98 1.66 1.66 2.30
Operating Cash Flow Coverage Ratio
0.00 0.90 38.09 16.93 0.00
Operating Cash Flow to Sales Ratio
0.00 0.17 0.13 0.05 0.26
Free Cash Flow Yield
0.00%-0.07%0.69%0.15%1.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
41.74 36.02 61.94 130.13 152.05
Price-to-Sales (P/S) Ratio
3.04 5.19 7.76 12.32 11.41
Price-to-Book (P/B) Ratio
3.18 5.29 7.15 11.21 9.66
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 -1.37K 144.87 647.99 76.78
Price-to-Operating Cash Flow Ratio
0.00 29.72 57.57 258.55 43.33
Price-to-Earnings Growth (PEG) Ratio
-2.07 1.47 1.10 2.80 1.44
Price-to-Fair Value
3.18 5.29 7.15 11.21 9.66
Enterprise Value Multiple
12.87 16.13 30.76 58.49 54.36
Enterprise Value
5.68B 11.22B 16.43B 22.45B 16.82B
EV to EBITDA
12.87 16.13 30.76 58.49 54.36
EV to Sales
2.09 4.19 6.62 10.74 9.44
EV to Free Cash Flow
0.00 -1.11K 123.54 564.56 63.53
EV to Operating Cash Flow
0.00 23.98 49.09 225.26 35.85
Tangible Book Value Per Share
277.71 243.66 258.72 221.93 205.29
Shareholders’ Equity Per Share
258.50 256.59 262.78 224.33 207.73
Tax and Other Ratios
Effective Tax Rate
0.34 0.32 0.30 0.29 0.37
Revenue Per Share
269.60 261.60 242.15 204.10 175.93
Net Income Per Share
19.69 37.67 30.35 19.33 13.20
Tax Burden
0.66 0.68 0.70 0.71 0.63
Interest Burden
0.99 1.00 1.07 0.94 1.00
Research & Development to Revenue
<0.01 <0.01 <0.01 <0.01 <0.01
SG&A to Revenue
0.03 0.38 0.38 0.40 0.39
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 1.21 1.08 0.36 2.21
Currency in JPY